$OCUL news
The latest OCUL stock news: headlines, filings, AI summaries and sentiment for $OCUL, updated around the clock.
- Ocular Therapeutix Reports Q3 2026 Financial Results and AXPAXLI Regulatory Update
- Ocular Therapeutix Outlines Axpaxli NDA Plan for Q4 2026 with Cash Runway Extending into 2028
- OCULAR THERAPEUTIX, INC - 8-K Filing
- OCULAR THERAPEUTIX, INC - 10-Q Filing
- OCULAR THERAPEUTIX, INC - 8-K Filing
- Ocular Therapeutix Advances AXPAXLI for Wet AMD Despite Rising Costs
- Ocular Therapeutix Reports Q2 GAAP EPS and Revenue Beats
- OCULAR THERAPEUTIX, INC - 8-K Filing
- Ocular Therapeutics Receives Positive FDA Feedback on AXPAXLI
- Acuta Capital Sells Majority Stake in Ocular Therapeutix
- Saturn V Capital Exits Ocular Therapeutix Position Worth $14 Million
- Ocular Therapeutix Reports Positive Phase 3 Trial Results for AXPAXLI in Wet AMD